![]() |
市場調查報告書
商品編碼
2149641
內視鏡止血裝置市場規模、細分、佔有率、監管、保險償付、介入措施及至2034年的預測Endoscopic Hemostasis Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告《內視鏡止血裝置市場規模、細分、佔有率、監管、保險償付、介入措施及至2034年的預測》目的是可視化內視鏡設備治療領域的定量和定性市場趨勢。
內視鏡止血裝置包括用於處理胃腸道出血的器械,通常作為第一線治療方法。內視鏡止血裝置一般分為機械裝置(止血夾、結紮器、縫合器、支架)、注射裝置(注射針)、熱能裝置(止血探針、止血鉗、加熱探針、氬等離子凝固術、射頻消融術、冷凍法)及局部裝置(止血噴霧劑)。
內視鏡止血術是一種用於治療消化道出血的技術,通常作為第一線治療方法。內視鏡止血術的適應症包括多種上消化道和下消化道出血。上消化道出血主要包括消化性潰瘍出血和食道靜脈曲張出血,而下消化道出血最常見的住院原因是憩室出血和良性肛門直腸出血。
針對39個目標國家,建構了基於引用資料、採用顏色編碼的市場模型,其中包含流行病學指標和治療人數。互動式Excel格式的交付成果包括貨幣價值、病例數、產品使用情況、平均售價、市場規模和企業市場占有率分析(如有)。此外,分析師的評論,包括定性見解,為定量資料提供了背景資訊。
市場模型的主要組成部分:
目前可用的內視鏡止血裝置及不斷變化的競爭格局:
對全球、區域和特定國家市場的具體見解:
透過獲得真正全面的概覽,包括對醫療保健系統的概述,可以加深對市場的理解。此外,在「市場進入」部分,可以利用有關償付政策和監管條件的資訊,更深入地了解市場動態。
憑藉可靠的調查方法和資料來源,該模型能夠提供全面且準確的市場概覽。來自需求方和供應方(包括關鍵意見領袖)的第一手資訊均整合到企業聯合組織模型中。此外,該模型還利用真實世界的資料來源來捕捉市場趨勢,包括政府手術資料庫、醫院採購資料庫和專有線上資料庫。
目標公司:Boston Scientific Corp、ConMed Corp、Wilson-Cook Medical Inc、ERBE Elektromedizin GmbH、Olympus Corp、United States Endoscopy Group Inc、Micro-Tech Nanjing Co Ltd、Integra LifeSciences Holdings Corp、Medline Industries LP、Diversatek Inc等。
目標國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利
這個市場模型提供了其他任何資訊來源都無法獲得的關鍵專家見解。它揭示了目標市場的定性和定量趨勢。以下人群必須閱讀此模型:
這將使該模型的應用成為可能。
Endoscopic Hemostasis Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.
Endoscopic Hemostasis Devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. Endoscopic Hemostasis Devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).
Endoscopic Hemostasis is a technique employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. The indications of endoscopic hemostasis technique include various upper and lower gastrointestinal bleeding diseases. Upper GI bleeding mainly includes peptic ulcer bleeding and variceal bleeding while diverticular bleeding and benign anorectal bleeding are the most common etiologies for hospital admissions with lower GI bleeding.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Endoscopic Hemostasis Devices and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, ConMed Corp, Wilson-Cook Medical Inc, ERBE Elektromedizin GmbH, Olympus Corp, United States Endoscopy Group Inc, Micro-Tech Nanjing Co Ltd, Integra LifeSciences Holdings Corp, Medline Industries LP, Diversatek Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -